Home / Companies / Regeneron Pharmaceuticals, Inc. / 12 Jun 2026
Regeneron Pharmaceuticals, Inc.: meeting of 12 Jun 2026
Votes reported on Form N-PX, item by item
1,349 Form N-PX filers reported votes at the Regeneron Pharmaceuticals, Inc. meeting of 12 Jun 2026. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
5 nominees; 73.8% of reported votes for; 203 filers withheld from or voted against at least one nominee.
5,520 vote records from 352 filers. 117 of the 350 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
2,374 vote records from 1,342 filers. 85 of the 1,301 filers that marked the item either way voted against management. 41 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
1,106 vote records from 351 filers. 8 of the 349 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
1 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Regeneron Pharmaceuticals, Inc. meeting?
1,349 Form N-PX filers reported votes at the meeting of 12 Jun 2026. On say-on-pay, 85 of 1,301 voted against management (6.5%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Regeneron Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Regeneron Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Regeneron Pharmaceuticals, Inc. with a meeting date within three days of 12 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.